Cardiovascular Research
Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy
Experiments in animalsInterventions
Papers by Zenouska Ramchunder
2 results
- npj Metabolic Health and Disease
Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice
Experiments in animalsInterventions